Lot Release Certificate View

Lot Release Number 2021-04-27-0185
FDA Registered Product/Generic Name EMICIZUMAB
Brand Name HEMLIBRA
Dosage Strength 60 mg/0.4 mL
Dosage Form SOLUTION FOR INJECTION (S.C.)
Registration Number BR-1332
Batch/Lot Number B3003
Packaging Lot Packaging Lot (Box): B3003B38
Product Expiration Date 30 December 2022
Issuance Date 30 April 2021